What does a Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) of 69% predicted and a Vital Capacity (VA) of 59% predicted on a Pulmonary Function Test (PFT) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of DLCO 69% and VA 59% Predicted

These values indicate a mild reduction in diffusing capacity (DLCO 69% predicted) with a moderately-to-severely reduced alveolar volume (VA 59% predicted), suggesting either restrictive lung disease with parenchymal involvement or incomplete lung inflation during the test. 1

Severity Classification

DLCO Severity:

  • Your DLCO of 69% predicted falls into the mild reduction category (>60% and <LLN) according to European Respiratory Society guidelines 1
  • This is above the threshold of 60% that predicts increased respiratory complications in surgical candidates 1

VA Interpretation:

  • VA of 59% predicted represents a moderate-to-severe reduction in the lung volume sampled during the single-breath test 1
  • This low VA can occur from true restrictive lung disease, incomplete inspiration during testing, or air trapping that prevents gas distribution 1

Critical Diagnostic Consideration: The DLCO/VA Relationship

The pattern of DLCO reduction being proportionally less than VA reduction is diagnostically significant:

  • When DLCO is reduced but DLCO/VA (KCO) is preserved or elevated, this suggests extraparenchymal restriction (chest wall disease, neuromuscular disorders, obesity, pleural disease, or pneumonectomy) rather than intrinsic lung parenchymal disease 1

  • When both DLCO and DLCO/VA are proportionally reduced, this suggests parenchymal lung disease (interstitial lung disease, emphysema, pulmonary vascular disease) 1

  • Calculate DLCO/VA: With your values, if DLCO/VA is normal or high, the lung tissue itself may be healthy but mechanically restricted 2

Essential Next Steps for Interpretation

You must obtain complete spirometry and lung volumes to properly interpret these values:

  1. Check FEV1/FVC ratio to distinguish obstruction from restriction 1

    • If FEV1/FVC is normal (>LLN) and TLC is reduced (<LLN), this confirms true restrictive physiology 1
    • If FEV1/FVC is reduced, consider obstructive disease (emphysema if DLCO low, asthma if DLCO normal) 1
  2. Measure TLC by body plethysmography - VA from single-breath DLCO systematically underestimates true TLC, especially with airflow obstruction, and cannot be used to diagnose restriction 1

  3. Review test quality - A low VA may reflect poor test technique (incomplete inspiration, breath-holding <10 seconds) rather than true pathology 1

Differential Diagnosis Based on Pattern

If spirometry shows restriction (low TLC, normal FEV1/FVC):

  • Normal DLCO/VA: Chest wall restriction, neuromuscular disease, obesity, pleural disease 1, 2
  • Low DLCO/VA: Interstitial lung disease, pulmonary fibrosis, sarcoidosis 1, 3

If spirometry shows obstruction (low FEV1/FVC):

  • Low DLCO: Emphysema phenotype of COPD 1, 4
  • Normal DLCO: Chronic asthma more likely 4

If spirometry and lung volumes are normal:

  • Isolated low DLCO: Consider pulmonary vascular disease, early interstitial lung disease, early emphysema, or anemia 1, 5, 4

Clinical Significance and Prognosis

  • DLCO <60% predicted is associated with increased surgical risk (25% mortality, 40% pulmonary morbidity in one series), but your value of 69% is above this threshold 1

  • DLCO <40% predicted is associated with significantly increased morbidity, mortality, and poor long-term survival 1, 4

  • A decline of >4 units or >10% in DLCO over time indicates disease progression and warrants treatment intensification 4, 3

Common Pitfalls to Avoid

  • Do not diagnose restriction based on VA alone - VA from DLCO testing underestimates TLC and requires confirmation with body plethysmography 1

  • Always correct DLCO for hemoglobin and carboxyhemoglobin - anemia falsely lowers DLCO, and failure to correct can lead to misdiagnosis 1

  • Examine DLCO and VA separately rather than relying solely on DLCO/VA, as their relationship provides pathophysiologic information 1

  • Consider test quality - poor effort, incomplete inspiration, or inadequate breath-hold can artificially lower both DLCO and VA 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Function Test Interpretation in Obesity-Related Restrictive Lung Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulmonary Function in Pulmonary Sarcoidosis.

Journal of clinical medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.